…
BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds, and hazardous air pollutants. The company offers biofilters; biotrickling filters; multi-stage systems; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. It also sells biofiltration media products under the BIOSORBENS, XLD, BIOPAK, BIOROLL, and BIOBLOK names. The company operates in Canada, the United States, China, and internationally. BioRem Inc. was founded in 1990 and is headquartered in Puslinch, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on BioRem Inc. (BRM.V) is limited; available filings and disclosures do not clearly describe the company's core operations or markets. The issuer appears to be a small-cap listing on the TSX Venture Exchange with no publicly documented revenue drivers or product roadmap. Investors may find potential upside if future disclosures demonstrate commercial traction, but should view the equity as speculative until fundamentals are documented.
The primary investment risks are sparse public disclosure, low trading liquidity and the execution and financing risks typical of micro‑cap issuers.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Income before tax | 4.15M | 2.79M | 2.38M | 2.03M | 2.68M |
| Net income | 3.04M | 2.18M | 1.61M | 1.30M | 2.09M |
| Selling general administrative | 5.62M | 1.63M | 3.20M | 1.82M | 2.80M |
| Selling and marketing expenses | - | 2.28M | 2.58M | 2.10M | 1.96M |
| Gross profit | 10.06M | 6.94M | 8.76M | 6.24M | 7.02M |
| Reconciled depreciation | 0.47M | 0.38M | 0.35M | 0.34M | 0.35M |
| Ebit | - | 3.09M | 2.88M | 2.33M | 2.56M |
| Ebitda | - | 3.47M | 3.23M | 2.68M | 2.92M |
| Depreciation and amortization | - | 0.38M | 0.35M | 0.34M | 0.35M |
| Operating income | 4.39M | 3.09M | 2.64M | 2.07M | 2.72M |
| Other operating expenses | - | 22.08M | 25.98M | 22.14M | 21.81M |
| Interest expense | 0.20M | 0.27M | 0.26M | 0.04M | 0.04M |
| Tax provision | 1.10M | 0.61M | 0.77M | 0.74M | 0.59M |
| Net interest income | -0.20M | -0.27M | -0.26M | -0.04M | -0.04M |
| Income tax expense | - | 0.61M | 0.77M | 0.74M | 0.59M |
| Total revenue | 37.42M | 25.17M | 28.86M | 24.48M | 24.38M |
| Total operating expenses | 33.03M | 3.85M | 5.88M | 3.90M | 4.46M |
| Cost of revenue | 27.36M | 18.23M | 20.10M | 18.24M | 17.36M |
| Total other income expense net | -0.05M | -0.30M | -0.24M | -0.26M | 0.16M |
| Net income from continuing ops | 3.04M | 2.18M | 1.61M | 1.30M | 2.09M |
| Net income applicable to common shares | - | - | - | 1.30M | 2.09M |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Total assets | 28.51M | 24.08M | 20.73M | 19.17M | 21.95M |
| Other current assets | - | 2.33M | - | 0.49M | 0.43M |
| Total liab | 17.89M | 17.36M | 16.21M | 17.20M | 8.43M |
| Total stockholder equity | 10.63M | 6.72M | 4.52M | 1.96M | 13.52M |
| Other current liab | - | 2.73M | - | 3.96M | 3.20M |
| Common stock | - | 5.00M | - | 4.91M | 17.20M |
| Capital stock | 5.20M | 5.00M | 4.91M | 4.91M | 17.20M |
| Retained earnings | 1.13M | -1.92M | -4.10M | -5.71M | -7.01M |
| Other assets | - | - | - | 1.86M | 2.26M |
| Cash | 5.21M | 2.29M | 3.78M | 4.47M | 8.87M |
| Total current liabilities | 15.02M | 13.89M | 12.92M | 13.23M | 7.82M |
| Current deferred revenue | - | 4.31M | - | - | - |
| Net debt | - | 1.89M | 0.50M | 0.54M | - |
| Short term debt | - | 0.72M | - | - | - |
| Short long term debt | 0.57M | 0.55M | 1.30M | 1.51M | - |
| Short long term debt total | - | 4.19M | - | - | - |
| Other stockholder equity | - | 2.37M | - | 0.60M | 1.14M |
| Property plant equipment | - | - | - | 1.15M | 1.42M |
| Total current assets | 24.52M | 20.60M | 17.77M | 16.17M | 18.28M |
| Net tangible assets | - | - | - | 1.96M | 13.52M |
| Net receivables | 11.90M | 15.08M | 8.36M | 10.13M | 7.60M |
| Long term debt | 1.86M | 2.43M | 2.98M | 3.50M | - |
| Inventory | 2.90M | 0.90M | 0.89M | 0.90M | 0.94M |
| Accounts payable | 4.02M | 6.14M | 4.71M | 5.07M | 1.81M |
| Accumulated other comprehensive income | - | 1.27M | - | - | - |
| Non current assets total | 3.99M | 3.47M | 2.96M | 3.00M | 3.68M |
| Capital lease obligations | 1.13M | 1.21M | 0.47M | 0.66M | 0.83M |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Investments | -0.37M | -0.55M | -0.20M | -0.08M | -0.34M |
| Change to liabilities | - | - | - | 3.49M | 0.96M |
| Total cashflows from investing activities | - | - | - | -0.08M | -0.34M |
| Net borrowings | -0.73M | - | - | 4.77M | -0.20M |
| Total cash from financing activities | -0.57M | -1.33M | -0.95M | -7.56M | -0.20M |
| Change to operating activities | - | - | - | 0.39M | 1.66M |
| Net income | 3.04M | 2.18M | 1.61M | 1.30M | 2.09M |
| Change in cash | 2.92M | -1.48M | -0.70M | -4.40M | 2.40M |
| Begin period cash flow | 2.29M | 3.78M | 4.47M | 8.87M | 6.47M |
| End period cash flow | 5.21M | 2.29M | 3.78M | 4.47M | 8.87M |
| Total cash from operating activities | 3.69M | 0.49M | 1.44M | 3.78M | 3.34M |
| Issuance of capital stock | 0.16M | 0.07M | 0.00M | - | - |
| Depreciation | 0.47M | 0.38M | 0.35M | 0.34M | 0.35M |
| Dividends paid | - | - | - | 5.09M | - |
| Change to inventory | -1.83M | -0.04M | 0.25M | 0.04M | 0.20M |
| Change to account receivables | 0.04M | -3.04M | -1.33M | -0.19M | -2.64M |
| Sale purchase of stock | - | - | 0.00M | -12.41M | - |
| Other cashflows from financing activities | - | -0.55M | -0.20M | 5.09M | -0.34M |
| Change to netincome | - | - | - | 0.44M | 0.58M |
| Capital expenditures | 0.37M | 0.55M | 0.20M | 0.08M | 0.34M |
| Change in working capital | -0.44M | -2.74M | -0.74M | 1.70M | 0.32M |
| Stock based compensation | 0.14M | 0.13M | 0.09M | 0.01M | 0.02M |
| Other non cash items | 0.08M | 0.08M | 0.04M | 0.05M | 0.04M |
| Free cash flow | 3.31M | -0.06M | 1.24M | 3.71M | 2.99M |
Sector: Industrials Industry: Pollution & Treatment Controls
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| BRM BioRem Inc. |
0.36 9.60% |
4.11 | 26.36 | 9.29 | 1.35 | 3.90 | 1.22 | 11.86 |
| TMG Thermal Energy International Inc. |
-0.01 3.12% |
0.15 | - | 21.98 | 0.92 | 6.18 | 0.89 | 17.14 |
| QST Questor Technology Inc. |
-0.01 1.85% |
0.27 | - | 6.00 | 1.22 | 0.42 | 0.72 | 9.32 |
| APL Appulse Corp |
- -% |
0.23 | - | - | 0.42 | 1.10 | 0.58 | 6.23 |
| SAY Sparta Capital Ltd |
- -% |
0.02 | - | - | 0.29 | 63.11 | 0.57 | 4.06 |
BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds, and hazardous air pollutants. The company offers biofilters; biotrickling filters; multi-stage systems; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. It also sells biofiltration media products under the BIOSORBENS, XLD, BIOPAK, BIOROLL, and BIOBLOK names. The company operates in Canada, the United States, China, and internationally. BioRem Inc. was founded in 1990 and is headquartered in Puslinch, Canada.
| Name | Title | Year Born |
|---|---|---|
| Mr. Derek S. Webb MBA, P.Eng. | CEO, Pres & Director | NA |
| Mr. Douglas Newman | CFO & Sec. | NA |
| Mr. Dan Costello | Director of Operations | NA |
| Mr. Mark Smit | Director of Technical Services | NA |
| Mr. Derek S. Webb MBA, P.Eng. | CEO, President & Director | NA |
| Mr. Douglas Newman | CFO & Secretary | NA |
| Mr. Douglas Newman BBA, CA, CPA | CFO & Secretary | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.